Abstract
Cellular interactions in the tumor stroma play a major role in cancer progression but can also induce tumor rejection. To explore the role of endothelial cells in these interactions, we used an in vitro three-dimensional collagen matrix model containing a cytotoxic T lymphocyte CTL clone (M4.48), autologous tumor cells (M4T), and an endothelial cell (M4E) line that are all derived from the same tumor. We demonstrate in this study that specific killing of the endothelial cells by the CTL clone required the autologous tumor cells and involved Ag cross-presentation. The formation of gap junctions between endothelial and tumor cells is required for antigenic peptide transfer to endothelial cells that are then recognized and eliminated by CTL. Our results indicate that gap junctions facilitate an effective CTL-mediated destruction of endothelial cells from the tumor microenvironment that may contribute to the control of tumor progression.
| Original language | English |
|---|---|
| Pages (from-to) | 2654-2664 |
| Number of pages | 11 |
| Journal | Journal of Immunology |
| Volume | 182 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 1 Mar 2009 |
| Externally published | Yes |
Fingerprint
Dive into the research topics of 'Gap junction communication between autologous endothelial and tumor cells induce cross-recognition and elimination by specific CTL'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver